MiR-142-3p is a paracrine mediator between T cells and endothelium during allograft rejection

被引：1
|
作者：
Gupta, Shashi K. [1 ]
Thum, Thomas [1 ,2 ,3 ]
机构：
[1] Hannover Med Sch, Inst Mol & Translat Therapeut Strategies, Carl Neuber Str 1, D-30625 Hannover, Germany
[2] Hannover Med Sch, Excellence Cluster REBIRTH, Carl Neuberg Str 1, D-30625 Hannover, Germany
[3] Imperial Coll, Natl Heart & Lung Inst, Sydney St, London SW3 6NP, England
来源：
CARDIOVASCULAR RESEARCH | 2017年 / 113卷 / 05期
关键词：
EXPRESSION; TRANSPLANTATION; MICRORNAS;
D O I：
10.1093/cvr/cvx031
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：431 / 433
页数：3
相关论文
共 50 条
  • [1] miR-142-3p balances proliferation and differentiation of mesenchymal cells during lung development
    Carraro, Gianni
    Shrestha, Amit
    Rostkovius, Jana
    Contreras, Adriana
    Chao, Cho-Ming
    El Agha, Elie
    MacKenzie, Breanne
    Dilai, Salma
    Guidolin, Diego
    Taketo, Makoto Mark
    Guenther, Andreas
    Kumar, Maya E.
    Seeger, Werner
    De Langhe, Stijn
    Barreto, Guillermo
    Bellusci, Saverio
    DEVELOPMENT, 2014, 141 (06): : 1272 - U180
  • [2] The Increase of Serum MiR-142-3p Level in Acute Cardiac Rejection as a Reflection of Exosome-Mediated Genetic Exchange Between T Cells and Endothelial Cells.
    Dewi, I.
    Hollander, Z.
    McManus, B.
    Gidloef, O.
    Oehman, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 504 - 504
  • [3] The Expression of miR-142-3p in Fatty Liver
    Henderson, Wendy A.
    Martino, Angela C.
    Del Valle-Pinero, Arseima Y.
    Peace, R. Michael
    Abey, Sarah
    GASTROENTEROLOGY, 2012, 142 (05) : S1021 - S1021
  • [4] Altered Serum miR-326 and miR-142-3p Profiles during Acute Rejection after Heart Transplantation.
    Dewi, I.
    Torngren, K.
    Gidlof, O.
    Kornhall, B.
    Ohman, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 546 - 546
  • [5] miR-142-3p Controls the Specification of Definitive Hemangioblasts during Ontogeny
    Nimmo, Rachael
    Ciau-Uitz, Aldo
    Ruiz-Herguido, Cristina
    Soneji, Shamit
    Bigas, Anna
    Patient, Roger
    Enver, Tariq
    DEVELOPMENTAL CELL, 2013, 26 (03) : 237 - 249
  • [6] MiR-142-3p in leukaemogenesis: tumour suppressor or oncomiR?
    Lagrange, Brice
    Martin, Romain Z.
    Droin, Nathalie
    Solary, Eric
    Bastie, Jean-Noel
    Delva, Laurent
    M S-MEDECINE SCIENCES, 2013, 29 (6-7): : 574 - 576
  • [7] Association of Serum MiR-142-3p and MiR-101-3p Levels with Acute Cellular Rejection after Heart Transplantation
    Dewi, Ihdina Sukma
    Hollander, Zsuzsanna
    Lam, Karen K.
    McManus, Janet-Wilson
    Tebbutt, Scott J.
    Ng, Raymond T.
    Keown, Paul A.
    McMaster, Robert W.
    McManus, Bruce M.
    Gidlof, Olof
    Ohman, Jenny
    PLOS ONE, 2017, 12 (01):
  • [8] miR-142-3p expression correlates with operational tolerance
    Helene Myrvang
    Nature Reviews Nephrology, 2012, 8 (4) : 194 - 194
  • [9] miR-142-3p regulates the formation and differentiation of hematopoietic stem cells in vertebrates
    Xinyan Lu
    Xiajuan Li
    Qiuping He
    Jiao Gao
    Ya Gao
    Bing Liu
    Feng Liu
    Cell Research, 2013, 23 : 1356 - 1368
  • [10] miR-142-3p Suppresses Invasion and Adhesion of Mesothelioma Cells by Downregulating ITGAV
    Endo, Ihiro
    Amatya, Vishwa Jeet
    Kushitani, Kei
    Nakagiri, Tetsuya
    Aoe, Kohei
    Takeshima, Yukio
    PATHOBIOLOGY, 2023, 90 (04) : 270 - 280
12345